Delivery Order SPE2DB24D2102-SPE2DB26FJHLT
- Not listed
- The Defense Logistics Agency awarded a $22,429.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4,021.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick medication, with an ultimate completion date of October 22, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under the company's larger pharmaceutical supply relationship with DLA. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,473.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 21, 2025. This non-set-aside competitive award was issued on October 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,958.07 to supply Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $26,823.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will take...
- The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This firm fixed-price delivery order, valued at $6,244.23, represents a non-competitive child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $1 billion agreement running through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $7,121.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of July 15, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $15,472.71 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a $7,085.19 delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB26FJHLTDelivery Order
The Defense Logistics Agency awarded a $24,163.14 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Repatha 140 mg/mL SureClick medication. This non-set-aside, firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters, with an ultimate completion date of October 23, 2025. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages its comprehensive pharmaceutical supply portfolio to support military and veteran healthcare systems. The Repatha delivery represents one of numerous competitively awarded orders under the company's prime IDC, which serves as a global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order fulfills medical supply needs within DLA's broader strategy to maintain pharmaceutical support across multiple therapeutic domains for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 10/22/25 |